These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 28290770)

  • 1. In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report.
    Gaedigk A; Twist GP; Farrow EG; Lowry JA; Soden SE; Miller NA
    Pharmacogenomics; 2017 Apr; 18(5):427-431. PubMed ID: 28290770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
    Streetman DS; Ellis RE; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?
    Gusella M; Pasini F; Corso B; Bertolaso L; De Rosa G; Falci C; Modena Y; Barile C; Da Corte Z D; Fraccon A; Toso S; Cretella E; Brunello A; Modonesi C; Segati R; Oliani C; Minicuci N; Padrini R;
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00646. PubMed ID: 32813313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
    McCune JS; Lindley C; Decker JL; Williamson KM; Meadowcroft AM; Graff D; Sawyer WT; Blough DK; Pieper JA
    J Clin Pharmacol; 2001 Jul; 41(7):723-31. PubMed ID: 11452704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine.
    Chen R; Wang H; Shi J; Hu P
    Int J Clin Pharmacol Ther; 2016 May; 54(5):330-6. PubMed ID: 26902503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.
    Köhler D; Härtter S; Fuchs K; Sieghart W; Hiemke C
    Pharmacogenetics; 1997 Dec; 7(6):453-61. PubMed ID: 9429230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice.
    Jurica J; Bartecek R; Zourkova A; Pindurova E; Sulcova A; Kasparek T; Zendulka O
    J Clin Pharm Ther; 2012 Aug; 37(4):486-90. PubMed ID: 22548589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activity of dextromethorphan O-demethylation in healthy Japanese volunteers carrying duplicated CYP2D6 genes: duplicated allele of CYP2D6*10 does not increase CYP2D6 metabolic activity.
    Ishiguro A; Kubota T; Ishikawa H; Iga T
    Clin Chim Acta; 2004 Jun; 344(1-2):201-4. PubMed ID: 15149890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformation.
    Abdel-Rahman SM; Leeder JS; Wilson JT; Gaedigk A; Gotschall RR; Medve R; Liao S; Spielberg SP; Kearns GL
    J Clin Pharmacol; 2002 Jan; 42(1):24-9. PubMed ID: 11808821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
    Gaedigk A; Bradford LD; Marcucci KA; Leeder JS
    Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2D6 phenotyping with dextromethorphan.
    Wojtczak A; Rychlik-Sych M; Krochmalska-Ulacha E; Skretkowicz J
    Pharmacol Rep; 2007; 59(6):734-8. PubMed ID: 18195464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.
    Abduljalil K; Frank D; Gaedigk A; Klaassen T; Tomalik-Scharte D; Jetter A; Jaehde U; Kirchheiner J; Fuhr U
    Clin Pharmacol Ther; 2010 Nov; 88(5):643-51. PubMed ID: 20881950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omission of the deconjugation step in urine analysis and the unaltered outcome of CYP2D6 phenotyping with dextromethorphan.
    Basci NE; Bozkurt A; Kayaalp SO; Sayal A; Isimer A
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):1-5. PubMed ID: 9625265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2D6 genotype and phenotype relationship in South Indians.
    Naveen AT; Prasanna T; Farzana BL; Rajan S; Adithan C
    J Postgrad Med; 2006; 52(4):253-6. PubMed ID: 17102541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphan.
    Kévorkian JP; Michel C; Hofmann U; Jacqz-Aigrain E; Kroemer HK; Peraldi MN; Eichelbaum M; Jaillon P; Funck-Brentano C
    Clin Pharmacol Ther; 1996 May; 59(5):583-92. PubMed ID: 8646830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.
    Gaedigk A; Isidoro-García M; Pearce RE; Sánchez S; García-Solaesa V; Lorenzo-Romo C; Gonzalez-Tejera G; Corey S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):859-64. PubMed ID: 20473659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
    Casner PR
    J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
    Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
    Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distinguishing CYP2D6 homozygous and heterozygous extensive metabolizers by dextromethorphan phenotyping].
    Chen SQ; Cai WM; Wedlund PJ
    Yao Xue Xue Bao; 1997 Dec; 32(12):924-7. PubMed ID: 11596190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.